Elevated serum transcobalamin levels in anaemia of rheumatoid arthritis: correlation with disease activity but not with serum tumour necrosis factor alpha and interleukin 6

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumour

Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha

British Journal of Dermatology ◽

10.1111/j.1365-2133.2005.06485.x ◽

2005 ◽

Vol 152 (4) ◽

pp. 794-799 ◽

Cited By ~ 43

Author(s):

A. Tsianakas ◽

P.H. Hoeger

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Elevated Serum ◽

Necrosis Factor Alpha ◽

Pityriasis Lichenoides ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumour

Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity

Diabetologia ◽

10.1007/s001250051000 ◽

1998 ◽

Vol 41 (7) ◽

pp. 860-861 ◽

Cited By ~ 30

Author(s):

Not Available Not Available

Keyword(s):

Insulin Resistance ◽

Tumour Necrosis ◽

Elevated Serum ◽

Type Ii ◽

Necrosis Factor Alpha ◽

Insulin Dependent ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumour

Serum levels of interleukin-6 and tumour-necrosis-factor-alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low-dose methotrexate

European Journal of Clinical Investigation ◽

10.1111/j.1365-2362.1994.tb02063.x ◽

1994 ◽

Vol 24 (1) ◽

pp. 73-75 ◽

Cited By ~ 11

Author(s):

T. C. WASCHER ◽

J. HERMANN ◽

R. BREZINSCHEK ◽

H. P. BREZINSCHEK ◽

M. WILDERS-TRUSCHNIG ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Low Dose ◽

Serum Levels ◽

Necrosis Factor Alpha ◽

Dose Methotrexate ◽

Factor Alpha ◽

FRI0051 Decrease of disease activity and disability and improvement of quality of life in patients with refractory long-standing rheumatoid arthritis treated with monoclonal anti-tumour necrosis factor-alpha antibody

10.1136/annrheumdis-2001.1180 ◽

2001 ◽

Author(s):

F Fantini ◽

L Sinigaglia ◽

S Zeni ◽

M Cagnoli ◽

P Colombelli ◽

...

Keyword(s):

Quality Of Life ◽

Rheumatoid Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity

Clinical Rheumatology ◽

10.1007/bf02206655 ◽

1991 ◽

Vol 10 (4) ◽

pp. 374-376 ◽

Cited By ~ 15

Author(s):

G. T. Espersen ◽

M. Vestergaard ◽

E. Ernst ◽

N. Grunnet

Keyword(s):

Rheumatoid Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response

Faculty Opinions recommendation of Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718325310.793492804 ◽

2014 ◽

Author(s):

Ronald van Vollenhoven

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Human Antibody ◽

Necrosis Factor Alpha ◽

Subcutaneous Injections ◽

Factor Alpha ◽

Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations

British Journal of Ophthalmology ◽

10.1136/bjo.87.5.548 ◽

2003 ◽

Vol 87 (5) ◽

pp. 548-550 ◽

Cited By ~ 22

Author(s):

J Prada

Keyword(s):

Gene Expression ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Pharmacokinetic-pharmacodynamic modeling of the inhibitory effect of erythromycin on tumour necrosis factor-alpha and interleukin-6 production

Fundamental and Clinical Pharmacology ◽

10.1046/j.1472-8206.2001.00054.x ◽

2001 ◽

Vol 15 (6) ◽

pp. 419-424 ◽

Cited By ~ 7

Author(s):

Henk-Jan Guchelaar ◽

Marc J. Schultz ◽

Tom van der Poll ◽

Richard P. Koopmans

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Inhibitory Effect ◽

Pharmacodynamic Modeling ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha

Clinical Nutrition ◽

10.1016/j.clnu.2013.04.012 ◽

2014 ◽

Vol 33 (1) ◽

pp. 150-155 ◽

Cited By ~ 11

Author(s):

Susannah J. King ◽

Ibolya B. Nyulasi ◽

Michael Bailey ◽

Tom Kotsimbos ◽

John W. Wilson

Keyword(s):

Cystic Fibrosis ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

High Serum ◽

Fat Free Mass ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽